EN 简
Molecular Therapy
2017年12月18日
Development of GPC3-Specific Chimeric Antigen Receptor-Engineered Natural Killer Cells for the Treatment of Hepatocellular Carcinoma
Min Yu, Hong Luo, Mingliang Fan, Xiuqi Wu, Bizhi Shi, Shengmeng Di, Ying Liu, Zeyan Pan, Hua Jiang, Zonghai Li
Protein & Cell
2017年09月19日
Efficient growth suppression in pancreatic cancer PDX model by fully human anti-mesothelin CAR T cells
Hua Jiang, Bo Song, Peng Wang, Bizhi Shi,Qixiang Li, Mingliang Fan, Shengmeng Di, Jie Yang,Zonghai Li
Molecular Therapy
2017年07月03日
A Fusion Receptor as a Safety Switch, Detection, and Purification Biomarker for Adoptive Transferred T Cells
Xiuqi Wu, Bizhi Shi, Jiqin Zhang, Zhimin Shi, Shengmeng Di, Minliang Fan, Huiping Gao, Hai Wang, Jianren Gu, Hua Jiang, Zonghai Li
Oncotarget
2017年05月16日
Treatment of hepatocellular carcinoma with a GPC3-targeted bispecific T cell engager
Yanyu Bi,*, Hua Jiang,*, Peng Wang, Bo Song, Huamao Wang, Xianming Kong, Zonghai Li
Cancer Immunol Immunother
2016年12月29日
Development of T cells carrying two complementary chimeric antigen receptors against glypican‑3 and asialoglycoprotein receptor 1 for the treatment of hepatocellular carcinoma
Cheng Chen, Kesang Li, Hua Jiang, Fei Song,Huiping Gao, Xiaorong Pan ·Bizhi Shi, Yanyu Bi, Huamao Wang, Hongyang Wang,Zonghai Li